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Introduction  
     Lifestyle-related diseases such as diabetes mellitus, cancer and arteriosclerosis are 
increasing yearly. Elderly persons are mainly affected and these conditions are referred to as 
aging-related diseases. Thus, prophylaxis for these diseases is important for maintenance of a 
healthy life. Aging progresses gradually and a method of delaying of senescence through food 
intake may be effective for prevention of aging-related disease. Many studies found that calorie 
restriction has big beneficial effects on health, with one study showing that calorie-restricted diet 
has a significant reduction in mortality and in age-associated diseases from a 25-year study of diet 
and aging in monkeys. However, calorie restriction is accompanied by considerable stress in 
humans, which makes it difficult to use as a usual lifestyle. 
     1-Deoxynojirimycin (DNJ) is a D-glucose analogue that is a characteristic constituent of 
mulberry (Moraceae) leaves (Fig. 1). Dietary mulberry DNJ may be beneficial for suppression of 
abnormally high blood glucose. In addition, we have shown anti-obesity and anti-lipid peroxidation 
effects of DNJ, with decreased serum insulin and glucose, improved carbohydrate metabolism, and 
decreased lipid peroxide levels. These beneficial effects may occur because DNJ can reduce the 
bioavailability of glucose and have a CR effect. Therefore, we carried out more in-depth and 
extensive research on the functionality of DNJ. This time, we studied the effect of 1-
Deoxynojirimycin on attenuating high glucose-accelerated senescence in human umbilical vein 
endothelial cells and whether 1-Deoxynojirimycin can prevents colorectal cancer in mice. 
 
 
 
 
Fig. 1 Chemical structures of 1-deoxynojirimycin (DNJ) and D-glucose.
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Chapter 1 
1-Deoxynojirimycin attenuates high glucose-accelerated senescence in human umbilical vein 
endothelial cells 
     The influence of 1-deoxynojirimycin (DNJ) derived from mulberry on senescence of 
endothelial cells was examined with the goal of discovery of a method for prevention of senescence 
of blood vessels. The effect of DNJ on senescence of human umbilical vein endothelial cells 
(HUVECs) promoted under high glucose condition was determined. HUVECs were cultured in 
normal glucose (5.6 mmol/L, NG group), normal glucose plus DNJ (10 µmol/L, DNJ group), high 
glucose (30 mmol/L, HG group), or high glucose plus DNJ (10 µmol/L, HG+DNJ group) and 
passaged until they reached senescence. The proliferation rate was markedly decreased in the HG 
group compared with the NG group, and this phenomenon was reversed by DNJ (Fig. 2). The 
frequency of senescent was evaluated by a SA-ß-Gal staining assay to detect senescent cells and 
observe the progression of senescence with increasing PDL. The rate of SA-ß-Gal-positive cells 
was significantly higher in the HG group compared with the NG group and this increase was 
suppressed by DNJ (Fig. 3). The expression level of senescence genes (PAI-1 and p21) were 
significantly higher in the HG group compared with the NG group, and these changes were blocked 
by DNJ (Table 1). To examine the effects of high glucose and DNJ on monocytic adhesion, 
HUVECs and calcein AM-labeled THP-1 cells were co-cultured. Monocytic adhesion was 
significantly greater in the HG group compared with the NG group and this increase was suppressed 
by DNJ (Fig. 4). mRNA levels of ICAM1, SELE, and VCAM1, which are cell adhesion molecules, 
were also significantly higher in the HG group compared with the NG group and these increases 
were suppressed by DNJ (Table 1). Additionally, the mRNA levels of ICAM1 and VCAM1 were 
significantly lower in the DNJ group compared with the NG group. Monocyte adhesion in HUVECs 
is promoted by NF-ĸB activation and ROS generation. NF-ĸB activity and ROS generation in 
HUVECs at PDL28-29 was significantly higher in the HG group compared with the NG group, with 
this increase suppressed by DNJ (Fig. 5). Therefore, these results show that DNJ delays cellular 
senescence that is promoted under high glucose condition [1].
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Fig. 2 Effects of DNJ on cell proliferation in HUVECs exposed to high glucose. (A) Growth curve showing the cumulative 
population doubling level (CPDL) from young to senescent. (B) The number of days required for HUVEC to reach PDL28 
was compared. Values are expressed as the mean ± SD (n = 10). *P < 0.05, **P < 0.01 (vs. NG). #P < 0.05, ##P < 0.01 (vs. 
HG). 
 
              
Fig. 3 Effects of DNJ on senescence of HUVECs exposed to high glucose. (A) Photographs of typical SA-ß-Gal-stained 
HUVECs and (B) percentages of SA-ß-Gal-positive HUVECs in the NG, DNJ, HG, and HG + DNJ groups. The data were 
shown by the ratio to young cells (normal-glucose exposed HUVECs at PDL8-9). Values are expressed as the mean ± SD (n 
= 10). *P < 0.05, **P < 0.01 (vs. NG). #P < 0.05, ##P < 0.01 (vs. HG). 
 
              
Fig. 4 Effects of DNJ on monocyte adhesion. (A) Photographs of typical fluorescence-stained THP-1 cells in HUVECs and 
(B) percentages of THP-1 cells in HUVECs in the NG, DNJ, HG, and HG + DNJ groups. The data were shown by the ratio 
to young cells (normal-glucose exposed HUVECs at PDL8-9). Values are expressed as the mean ± SD (n = 10). *P < 0.05, 
**P < 0.01 (vs. NG). #P < 0.05, ##P < 0.01 (vs. HG). 
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Fig. 5 Effects of DNJ on NF-ĸB activation and ROS generation in high-glucose exposed HUVECs. (A) Proportion of NF-ĸB 
activation and (B) ROS generation in the NG, DNJ, HG, and HG + DNJ groups based on a H2DCFDA assay. The data were 
shown by the ratio to young cells (normal-glucose exposed HUVECs at PDL8-9). Values are expressed as the mean ± SD (n 
= 10). *P < 0.05, **P < 0.01 (vs. NG). #P < 0.05, ##P < 0.01 (vs. HG). 
 
 
Table 1 Effects of DNJ on mRNA expression for genes related to cellular senescence and monocyte adhesion. 
 
The mRNA expression of 5 genes related to cellular senescence and adhesion molecules in NG, DNJ, HG, and HG+DNJ 
groups was determined by using qRT-PCR. The data were shown by the ratio to young cells (normal-glucose exposed 
HUVECs at PDL8-9). Values are expressed as the mean ± SD (n=10). *P < 0.01, **P < 0.01 (vs. NG); #P <0.05, ##P <0.01 (vs. 
HG). NG; normal-glucose exposed HUVECs at PDL28-29, DNJ; normal-glucose and 10 µmol/L DNJ exposed HUVECs at 
PDL28-29, HG; high-glucose exposed HUVECs at PDL28-29, HG+DNJ; high-glucose and 10 µmol/L DNJ exposed 
HUVECs at PDL28-29.  
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PAI-1 
p21 
ICAM1 
SELE 
VCAM1 
3.63 ± 0.37 
2.12 ± 0.18 
6.44 ± 1.06 
7.73 ± 1.93 
6.64 ± 0.89 
2.53 ± 0.37* 
2.09 ± 0.09 
3.44 ± 0.66* 
6.99 ± 0.83 
5.04 ± 0.51* 
5.45 ± 0.59* 
4.41 ± 0.34** 
16.14 ± 2.30** 
23.00 ± 3.63** 
13.66 ± 2.30*
2.68 ± 0.47## 
2.87 ± 0.37# 
4.01 ± 0.25## 
9.52 ± 1.73## 
5.49 ± 2.12# 
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Chapter 2 
Intake of mulberry 1-deoxynojirimycin prevents colorectal cancer in mice 
     1-Deoxynojirimycin (DNJ) is a D-glucose analogue that is a characteristic constituent of 
mulberry (Moraceae) leaves. We previously have shown anti-obesity and anti-lipid peroxidation 
effects of DNJ, with decreased serum insulin and glucose, improved carbohydrate metabolism, and 
decreased lipid peroxide levels. These beneficial effects may occur because DNJ can reduce the 
bioavailability of glucose and have a caloric restriction (CR) effect. Moreover, DNJ intake showed 
changes in lipid metabolic parameters like CR. Cancer cells require larger amounts of glucose than 
normal cells, which suggests that growth of these cells might be inhibited by DNJ.  
     Screening for agents for colorectal cancer prevention has been carried out in mouse models 
using the potent carcinogen azoxymethane (AOM), which induces colorectal cancers at a high 
incidence. Dextran sodium sulfate (DSS), a colitis-inducing agent, can be used after AOM to make 
a two-stage mouse colorectal cancer model. In this study, the effect of DNJ, a CR mimetic, was 
examined in ICR mice with AOM/DSS-induced colorectal cancer. AOM is a carcinogen (10mg/kg 
body weight), and 2%DSS (w/v) used as a colitis-inducing agent. Mice were separated into 5 groups: 
a group without colorectal cancer fed a normal diet (CO- group), and groups with colorectal cancer 
fed a normal diet (CO+ group), a calorie-restricted diet (CR group), and diets including 0.02% and 
0.1% DNJ (L-DNJ and H-DNJ groups). There were significant decreases in food and energy intake 
in the CR group compared to the CO− and CO+ groups (Table 2). In contrast, there were significant 
increases in food and energy intake in the H-DNJ group compared to the CO− group (Table 2).  
The number of colonic tumors visible with the naked eye was counted after sacrifice (Fig. 6 I). H&E 
staining of colon tissues to confirm the occurrence of a tumor (adenoma and adenocarcinoma) 
showed colon inflammation (Fig. 6 II-B), adenoma (Fig. 6 II-C) and adenocarcinoma (Fig. 6 II-D) 
in mice with induced cancer, but normal tissue (Fig. 6 II-A) in the control group (CO−). The tumor 
incidence and number were reduced significantly in the CR group compared to the CO+ group, and 
were also suppressed in a dose-dependent manner by 1-deoxynojirimycin (Fig. 7). There was a 
significant decrease in insulin in the L-DNJ and H-DNJ groups compared to the CO+ group (Table 
3). There were significant increases in serum and liver TBARS in the CR group compared to the H-
DNJ group, and TBARS decreased dose-dependently with DNJ (Table 3). mRNA for anti-apoptotic 
Bcl-2 was decreased and that for pro-apoptotic Bax was increased in the carcinoma tissue of CR, 
L-DNJ and H-DNJ groups (Fig. 8). These results suggest that CR and 1-deoxynojirimycin inhibit 
growth of colorectal cancer by inducing apoptosis in an induced cancer model in mice [2].
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Fig. 6 Effect of caloric restriction and DNJ on colon tissue in male mice with induced colorectal cancer. (II) Colon tissue in 
each group. Arrows indicate tumors. (I) Representative histology images from hematoxylin and eosin stained colon 
specimens (magnification ×4): (A) normal colon, (B) colon tissue with mild pathology, (C) dysplastic crypts, and (D) well 
differentiated tubular adenocarcinoma. Bars indicate 100 µm. 
 
           
Fig. 7 Effect of caloric restriction and DNJ on tumor incidence (I) and number (II) in male mice with induced colorectal 
cancer. Values are means ± SE, n = 18–20. a,b p<0.05. 
 
       
         
Fig. 8 Effect of caloric restriction and DNJ on BAX (I), Bcl 2 (II), and Sirt 1 (III) mRNA levels in male mice with induced 
colorectal cancer. Values are means ± SE, n = 18–20. a,b p<0.05.  
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Table 2 Effect of calorie restriction and DNJ on growth parameters in colon cancer-induced male mice. 
Values are means ± SE, n = 18–20. Means in a row with different letters are significantly different at p<0.05. 
 
 
Table 3 Effect of calorie restriction and DNJ on plasma, liver and colon parameters in colon cancer-induced male mice. 
Values are means ± SE, n = 18-20. Means in a row with different letters are significantly different at P < 0.05. HOMA-IR, 
homeostasis model assessment-insulin resistance; TBARS, thiobarbituric acid reactive substances; ALT, alanine 
transaminase; AST, aspartate aminotransferase. 
 
     CO-    CO+    CR   L-DNJ   H-DNJ 
Food intake (g/d) 5.41 ± 0.04b 5.69 ± 0.08 bc 4.45 ± 0.07 a 5.66 ± 0.09 bc 5.72 ± 0.08 c 
Energy intake (kcal/day) 18.7 ± 0.15 b 19.6 ± 0.28 bc 15.4 ± 0.20 a 19.5 ± 0.31 bc 19.7 ± 0.27 c 
Final body weight (g) 44.5 ± 0.91 43.8 ± 0.79 41.4 ± 0.32 43.0 ± 0.39  41.7 ± 0.67 
Tissue weight (g/100g body weight)     
Liver 4.09 ± 0.06 4.49 ± 0.13 4.33 ± 0.15 4.47 ± 0.09  4.38 ± 0.13 
Pancreas 0.85 ± 0.03 0.93 ± 0.04 0.90 ± 0.04 0.93 ± 0.04  0.92 ± 0.04 
Kidney 1.82 ± 0.03 a 1.92 ± 0.05 ab 1.90 ± 0.04 ab 2.03 ± 0.04 b   1.89 ± 0.06 ab 
Epididymis adipose  1.46 ± 0.18 a 1.09 ± 0.12 ab 0.79 ± 0.12 b 0.80 ± 0.11 b  0.77 ± 0.13 b 

    CO-   CO+    CR   L-DNJ   H-DNJ 
Serum      
  Triacylglycerol (mmol/L)     1.51 ± 0.09 1.57 ± 0.09 1.50 ± 0.10 1.72 ± 0.14 1.45 ± 0.11 
  Total cholesterol (mmol/L)    2.32 ± 0.06 ab 2.19 ± 0.04 a 2.11 ± 0.06 a 2.55 ± 0.08 b 2.23 ± 0.07 a 
  Phospholipid (mmol/L)     2.24 ± 0.04 a 2.15 ± 0.05 a 2.14 ± 0.07 a 2.51 ± 0.09 b 2.24 ± 0.08 a 
  Glucose (mmol/L) 4.57 ± 0.20 5.03 ± 0.26 5.00 ± 0.18 4.69 ± 0.21 5.04 ± 0.28 
  Insulin (mg/L) 0.24 ± 0.03 ab 0.26 ± 0.04 a 0.25 ± 0.03 ab 0.15 ± 0.01 b 0.15 ± 0.01 b 
  HOMA-IR 1.00 ± 0.15 1.20 ± 0.20 0.66 ± 0.06 0.65 ± 0.06 0.66 ± 0.07 
  TBARS (µmol/L) 5.14 ± 0.21 ab 5.47 ± 0.48 ab 6.17 ± 0.23 b 4.90 ± 0.29 ab 4.27 ± 0.25 b 
  ALT (UI/L) 9.75 ± 0.42 10.4 ± 0.52 10.0 ± 0.54 9.50 ± 0.92 11.5 ± 0.57 
AST (UI/L) 53.0 ± 5.44 a 61.0 ± 7.89 b 46.5 ± 5.28 a 44.7 ± 3.32 a 43.5 ± 2.41 a 
Liver       
  Triacylglycerol (µmol/g)    12.2 ± 1.13 8.82 ± 0.84 11.0 ± 1.21 13.0 ± 1.34 10.7 ± 1.39 
  Total cholesterol (µmol/g)    7.68 ± 0.65 7.84 ± 0.73 7.02 ± 0.20 6.45 ± 0.50 6.55 ± 0.41 
  Phospholipid (µmol/g)     34.5 ± 0.8 32.7± 1.4 35.4 ± 1.0 35.5 ± 1.2 34.6 ± 1.4 
  TBARS (nmol/g) 68.9 ± 5.3a 63.6 ± 3.9a 44.7 ± 2.8b 59.5 ± 3.1a 41.1 ± 3.3b 
Colon      
  TBARS (nmol/g) 8.6 ± 0.7a 21.2 ± 1.3c 14.9 ± 0.9b 18.8 ± 1.0c 13.7 ± 1.1b 
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Conclusion  
     In the present study, we focused on the effects of DNJ on high glucose-accelerated 
senescence and colorectal cancer.  
     We have previously shown that senescent HUVECs have increased levels of proteins that 
promote monocyte adhesion. In the first study, senescence of HUVECs promoted monocyte 
adhesion and this effect was markedly increased by high glucose and suppressed by DNJ. 
Monocyte adhesion occurs in the first stage of arteriosclerotic. Therefore, intake of DNJ might be 
effective for prophylaxis of arteriosclerosis. Expression of monocyte adhesion molecules is 
induced by NF-kB and ROS, and we found that senescence of HUVECs activated NF-kB and 
increased ROS production, with these changes promoted by high glucose and suppressed by DNJ. 
Additionally, in this study, ROS generation was significantly lower in the DNJ group compared 
with the NG group. These findings suggest that DNJ behaves as an antioxidant, decreases ROS 
production, and delays cellular senescence. Attenuation of high glucose-accelerated senescence by 
decreasing ROS levels may make DNJ useful as a health food supplement and medicine. Further 
studies are needed to determine the mechanisms underlying these effects. 
     In the second study, we also showed that caloric restriction inhibits AOM/ DSS-induced 
colorectal cancer in ICR mice, and that DNJ suppresses this disease through a caloric restriction-
like mechanism. This is the first report of a colorectal cancer preventive effect of DNJ. Caloric 
restriction is a potential approach to prevention of colorectal cancer, but eliminating food intake is 
also stressful. Therefore, a caloric restriction mimetic such as DNJ would be ideal for cancer 
prevention. In this study, we showed the efficacy of DNJ for this purpose. Determination of the 
appropriate dose of DNJ and understanding of the detailed mechanism of the colorectal cancer 
preventive effect of DNJ will require further studies.  
212
 
Reference  
 
[1] E S, Kijima R, Honma T, Yamamoto K, Hatakeyama Y, Kitano Y, Kimura T, Nakagawa K, 
Miyazawa T, Tsuduki T.1-Deoxynojirimycin attenuates high glucose-accelerated senescence in 
human umbilical vein endothelial cells. Exp Gerontol. 2014 Jul; 55:63-9.  
 
[2] E S, Yamamoto K, Sakamoto Y, Mizowaki Y, Iwagaki Y, Kimura T, Nakagawa K, Miyazawa T, 
Tsuduki T. Intake of mulberry 1-deoxynojirimycin prevents colorectal cancer in mice. J Clin 
Biochem Nutr. 2017 Jul;61(1):47-52.  

213
論文審査の結果の要旨及び担当者
氏 名 鄂 爽
審 査 委 員
主査：准教授 都築 毅 
副査：教授 戸田 雅子  教授 仲川 清隆  准教授 白川 仁 
学 位 論 文 題 目
Study on novel physiological function of 1-deoxynojirimycin derived 
from mulberry leaves 
(桑葉由来 1-デオキシノジリマイシンの新規生理機能に関する研究) 
論 文 審 査 の 結 果 の 要 旨
本論文は、桑葉由来の１－デオキシノジリマイシン（DNJ）が老化と大腸癌に対して
どのような効果を示すのか検討した。
第 1章では、培養細胞試験を行った。ヒト内皮細胞（HUVEC）が老化すると、単球接
着が増加することが明らかとなっている。そこに DNJが存在すると、HUVECの老化は
遅延し、単球接着を抑制することが示された。単球接着は動脈硬化症の最初に見られる
現象のため、DNJの摂取は動脈硬化の予防に効果があると示唆された。HUVECにおけ
る単球接着分子の発現は、NF-κBによって促進されるため、DNJの存在下で、NF-κBの
活性が変化するか検討し、DNJはNF-κBの活性を抑えることが認められた。NF-κBの
活性は活性酸素種（ROS）によって誘導されるため、DNJの存在下で、ROSの産生量が
変化するか検討し、DNJは ROSの産生を抑えることが認められた。以上より、DNJは
HUVECにおいて酸化を抑制し、ROS産生を減少させ、細胞老化を遅らせたことが示唆
された。  
第 2章では、カロリー制限がマウスの AOM/DSS誘発大腸癌を抑制すること、および、
DNJ がカロリー制限様成分であることから、DNJ は大腸癌を抑制することが期待でき
た。よって、DNJの大腸癌に対する影響を検討した。その結果、DNJは容量依存的に、
大腸癌の発生を抑制し、このメカニズムに癌細胞選択的にアポトーシスを誘導すること
が見出された。
以上の内容は、世界で初めて発見された DNJの機能であり、国際誌に原著論文 2報と
して掲載されている。よって、審査員一同は本論文提出者（鄂爽）に対して博士（農学）
の学位を授与するに値すると判定した。
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